Evidence map›Paper›PMID 38543963›Full record

ArticleVaccines2024

Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic.

Laurynas Mockeliunas, Rob C van Wijk, Caryn M Upton, Jonathan Peter, Andreas H Diacon, Ulrika S H Simonsson

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Laurynas MockeliunasDepartment of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden.ORCID 0000-0002-7008-4946
Rob C van WijkDepartment of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden.
Caryn M UptonTASK, Cape Town 7500, South Africa.
Jonathan PeterAllergy and Immunology Unit, University of Cape Town Lung Institute and Division of Allergy and Clinical Immunology, University of Cape Town, Cape Town 7700, South Africa.
Andreas H DiaconTASK, Cape Town 7500, South Africa.
Ulrika S H SimonssonDepartment of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden.ORCID 0000-0002-3424-9686
Uppsala University · SETask Applied Science · ZAUniversity of Cape Town · ZA

Funding

European & Developing Countries Clinical Trials Partnership RIA2020EF-2968
6 · The paper itself

Abstract

(1) Background: Some individuals are more susceptible to developing respiratory tract infections (RTIs) or coronavirus disease (COVID-19) than others. The aim of this work was to identify risk factors for symptomatic RTIs including COVID-19 and symptomatic COVID-19 during the coronavirus pandemic by using infection incidence, participant baseline, and regional COVID-19 burden data. (2) Methods: Data from a prospective study of 1000 frontline healthcare workers randomized to Bacillus Calmette-Guérin vaccination or placebo, and followed for one year, was analyzed. Parametric time-to-event analysis was performed to identify the risk factors associated with (a) non-specific symptomatic respiratory tract infections including COVID-19 (RTIs+COVID-19) and (b) symptomatic RTIs confirmed as COVID-19 using a polymerase chain reaction or antigen test (COVID-19). (3) Results: Job description of doctor or nurse (median hazard ratio [HR] 1.541 and 95% confidence interval [CI] 1.299-1.822), the reported COVID-19 burden (median HR 1.361 and 95% CI 1.260-1.469 for 1.4 COVID-19 cases per 10,000 capita), or a BMI > 30 kg/m

Indexed as

COVID-19pharmacometricsrespiratory tract infectionsrisk factorstime-to-event analysis

Identifiers

PMID38543963
PMCPMC10974083
OpenAlexW4393005018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.